Janney Montgomery Scott’s CareDx CDNA Stock Holding History

Janney Montgomery Scott’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$367K	Sell	12,861 -5,347	-29%	-$116K	﹤0.01%	2600
2026 Q1	$316K	Sell	18,208 -2,100	-10%	-$39.7K	﹤0.01%	2342
2025 Q4	$383K	Hold	20,308	–	–	﹤0.01%	2386
2025 Q3	$295K	Sell	20,308 -840	-4%	-$12K	﹤0.01%	2506
2025 Q2	$413K	Hold	21,148	–	–	﹤0.01%	2145
2025 Q1	$375K	Buy	+21,148	New	+$455K	﹤0.01%	2173
2024 Q4	–	Sell	-21,463	Closed	-$670K	–	2713
2024 Q3	$670K	Hold	21,463	–	–	﹤0.01%	1765
2024 Q2	$333K	Sell	21,463 -1,050	-5%	-$12.7K	﹤0.01%	2151
2024 Q1	$238K	Buy	+22,513	New	+$225K	﹤0.01%	2475
2022 Q2	–	Sell	-6,195	Closed	-$229K	–	2324
2022 Q1	$229K	Sell	6,195 -320	-5%	-$12.5K	﹤0.01%	2018
2021 Q4	$296K	Buy	+6,515	New	+$340K	﹤0.01%	2006
2018 Q1	–	Sell	-12,308	Closed	-$90K	–	1944
2017 Q4	$90K	Buy	+12,308	New	+$76.7K	﹤0.01%	1885

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janney Montgomery Scott's CDNA Position: Q2 2026 in Review

Janney Montgomery Scott reduced its CareDx (CDNA) stake by 29% in Q2 2026, selling an estimated $116K and leaving 12,861 shares worth $367K. The position accounts for ﹤0.01% of the portfolio, ranked #2600.

Janney Montgomery Scott first reported a position in CDNA in Q4 2017 and has held it in 12 quarters since. The position peaked at $670K in Q3 2024. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

Janney Montgomery Scott held 12,861 shares of CareDx worth $367K as of Q2 2026.
Janney Montgomery Scott sold 5,347 CareDx shares in Q2 2026, an estimated $116K.
CareDx made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2600 holding.
Janney Montgomery Scott first reported a position in CareDx in Q4 2017 and has held it in 12 quarters since.
Janney Montgomery Scott's CareDx position peaked at $670K in Q3 2024.
227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.